AzTrials
AzTrials

Difficult IV AccessNCT03745209

Ultrasound-guided Peripheral IV vs. Standard Technique in Difficult Vascular Access Patients by ICU Nurses

A study testing Ultrasound in people with Difficult IV Access, run by Queen's University at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a randomized controlled single-center study that will be conducted in the intensive care unit. The main objective of this study is to assess the success rate of ultrasound-guided peripheral intravenous cannulation in ICU patients with difficult intravenous access compared with traditional landmark technique. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Difficult IV Access
What is being tested?
Ultrasound
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteCanada
Study dates
21 Jan 2019to 21 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years of age or older
  • Difficult IV access patients after 2 failed attempts

Who cannot join

  • Upper-extremity cellulitis
  • Unstable and need urgent intravenous access( central line or IO).

Trial locations and contacts

1 site in 1 country.

Mohammed R ALshamsi, MD contact

3433333986

17mras@queensu.ca

Fadi A Alsulaimi, MD contact

343-333-0941

17fhas@queensu.ca

Canada1 site, 1 recruiting
  • Kingston General Hospital

    Kingston, Ontario, K7L 2V7

    Mohammed R Alshamsi, MD, 3433333986, 17mras@queensu.ca

    Gordon Boyd, MD, 613-549-6666, boydj@kgh.kari.net

    Recruiting

Other trials in Canada

About this study

This is a randomized controlled single-center study that will be conducted in the intensive care unit. The main objective of this study is to assess the success rate of ultrasound-guided peripheral intravenous cannulation in ICU patients with difficult intravenous access compared with traditional landmark technique.

Read the detailed description

Peripheral IV access is common and essential procedure conducted by nurses in intensive care departments. This important procedure is frequently difficult because of the high prevalence of peripheral edema and obesity among ICU patients. In this study, the investigators will assess the success rate of real-time ultrasound guidance in cannulating difficult access ICU patients. This is a randomized controlled single-site trial with two groups in a parallel design. In this study, the investigators will compare the success rate of ultrasound-guided peripheral intravenous access (experimental group) to a traditional landmark approach (control group) in patients with difficult IV access. It is a non-blinded study because of the nature of the intervention. This study will be conducted in the adult intensive care unit of Kingston general hospital which is an urban university teaching hospital with 33 ICU beds and more than 1000 ICU admissions per year. A sample of ICU patients with difficult cannulation will be selected and enrolled in this study. Difficult cannulation is defined as poorly visible and poorly palpable upper extremities veins due to any cause after two failed attempts using the traditional technique. All consecutive patient with difficult cannulation will be assessed for enrolment in this study starting from October 2018 till March 2019. A research assistant will be available for patient enrollment and data collection between 8:00 AM to 5:00 PM during regular working hours.

The study will be conducted in two phases. Phase 1 will involve education and training of a cohort of nurses to perform US-guided cannulation. Experienced ICU nurses with two years of experience will be recruited to participate in the study. All nurses will have no prior experience in ultrasound-guided peripheral I.V insertion prior to this study. Education consists of didactic 2 hours lecture and hands-on practice on synthetic training models ( blue phantoms). This will cover basic machine operation, image optimization, sonographic anatomy and ultrasound techniques for guiding peripheral I.V cannulation. This will be followed by 2-3 months observation period during which nurses have to perform at least 15 successful ultrasound-guided peripheral cannulations on live subjects before actual patients' enrolment. Phase 2 will involve enrolment of difficult peripheral access ICU patients meeting specific inclusion and exclusion criteria. Patients will be systematically randomized to the ultrasound-guided or the landmark technique using envelop randomization.

Only upper limb veins will be selected for cannulation. All the cannulation will be done under semi aseptic technique as per standard placement and cleaning procedures for peripheral IV access. Ultrasound-guided cannulation will be performed using sterile gel for the procedure and the ultrasound probe will be covered with sterile adhesive films (e.g., 3M Tegaderm). Two already available departmental ultrasound machines (sonosite edge) will be used for this study. High-frequency probe (5-10 MHz) with single operator out of plane (short access) approach will be used for ultrasound-guided cannulation. When using ultrasound for I.V placement, veins deeper than 1.5 cm from the skin surface and veins with a diameter of less than 0.3 cm will be avoided because of high failure rate and increased risk of extravasation. Catheter length and size will be selected based on the depth and size of the veins to ensure that a sufficient portion of the catheter will remain in the vessel to prevent early failure.

Intensive care nurses participating in the study will record all the data related to outcome measures on a preprinted data collection forms.The Investigators will enter the raw data into SPSS software for analysis. An intention-to-treat analysis will be performed. Using the power of 80% and alpha of 0.05, the sample size was calculated to be 25 per group. Categorical variables such as success rate, catheter survival rate and complication rate will be presented as a percentage and will be compared using Fisher exact tests. Continuous variables such as insertion time and the number of attempts will be shown as mean, median (with interquartile ranges), and 95% confidence interval (CI) and will be compared using Mann-Whitney U tests. All statistical analysis will be conducted using IBM SPSS Base 25 for Windows.

Being tested
Ultrasound
Keywords
Peripheral IV, Difficult, Ultrasound-guided

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • UltrasoundDevice

    Use of real-time ultrasound in an attempt to establish intravenous peripheral catheter.

Study groups in NCT03745209
Study groupRoleWhat they receive
Ultrasound-guided peripheral IV.ExperimentalUltrasound-guided peripheral IV cannulation
Receives: Device: Ultrasound
Traditional landmark techniqueNo interventionTraditional landmark technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall success rate of IV placement

    Ability to establish a functioning peripheral IV catheter

    Measured: Up to 30 minutes

Secondary outcomes (4)
  1. Number of skin punctures attempted.

    An attempt is defined as puncturing skin without need for reinsertion.

    Measured: Up to 30 minutes

  2. 24 hours catheter survival

    Functioning catheter 24 hours post insertion

    Measured: 24 hours post IV insertion

  3. Complications

    One of the following is defined as a complication related to peripheral IV insertion: cellulitis, phlebitis, arterial puncture, nerve injuries, infiltration.

    hematoma formation)

    Measured: Up to 7 days

  4. Subsequent need for PICC or central line.

    Subsequent need for PICC or central line

    Measured: Up to 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2018
  2. Study start21 Jan 2019
  3. Primary completion21 Jun 2019 (estimated)
  4. Study completion21 Jun 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03745209
Sponsor's protocol ID
6023923
Status last verified
Feb 2019
First submitted
9 Sep 2018
Last updated
12 Feb 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Tada M, Yamada N, Matsumoto T, Takeda C, Furukawa TA, Watanabe N. Ultrasound guidance versus landmark method for peripheral venous cannulation in adults. Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD013434. doi: 10.1002/14651858.CD013434.pub2.

    PubMed 36507736

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound in people with Difficult IV Access, run by Queen's University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohammed R ALshamsi, MD (3433333986, 17mras@queensu.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall success rate of IV placement (time frame: Up to 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03745209, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in